Indications and uses
Indications and usage: Melt onto fingers and softly spread it on the lips
TONYMOLY KISS KISS LIP ESSENCE BALM
- Manufacturer
- TONYMOLY CO., LTD.
- Effective date
- 2014-06-25
- Label type
- HUMAN OTC DRUG LABEL
- Version
- 1
- Source
- full-release
- Hydrated at
- 2026-05-31 22:39:36
Label at a glance#
ProductTONYMOLY KISS KISS LIP ESSENCE BALM
Active ingredientOCTINOXATE
Label structure8 sections
Dosage and administration
Dosage and administration: Take an adequate amount of this product.
Label contents#
Full prescribing information#
ACTIVE INGREDIENT
Active Ingredient: Ethylhexyl Methoxycinnamate 5%
INACTIVE INGREDIENT
Inactive Ingredients:
Polyglyceryl-2 Triisostearate, Polybutene, Diisostearyl Malate, Petrolatum, Pentaerythrityl Tetraethylhexanoate, Microcrystalline Wax, Benzophenone-3, Hydroxystearic Acid, Silica Dimethyl Silylate, Phytosteryl/Isostearyl/Cetyl/Stearyl/Behenyl Dimer Dilinoleate, Glyceryl Behenate, Polyglyceryl-6 Octastearate, Fragrance(Parfum), Butylparaben, Tocopheryl Acetate, Yellow 6 Lake (CI 15985), Water, Honey Extract
PURPOSE
Purpose: Sunscreen
WARNINGS
Warning:
1. In case of having following symptoms after using this, you're advised to stop using it immediately. If you keep using it, the symptoms will get worse and need to consult a dermatologist.
1) In case of having problems such as red rash, swollenness, itching, stimulation during usage.
2) In case of having the same symptoms above on the part you put this product on by direct sunlight.
2. You are banned to use it on the part where you have a scar, eczema, or dermatitis.
3. In case of getting it into your eyes, you have to wash it immediately.
KEEP OUT OF REACH OF CHILDREN
Keep out of reach of babies and children
INDICATIONS AND USAGE
Indications and usage: Melt onto fingers and softly spread it on the lips
DOSAGE AND ADMINISTRATION
Dosage and administration: Take an adequate amount of this product.
PACKAGE LABEL.PRINCIPAL DISPLAY PANEL
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 59078-046-01 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-ca9f-f424-e053-dadaa90a57ce | 71b73c2e-bdb8-4202-b491-42f2b7881e05 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 59078-046-01 | TONYMOLY KISS KISS LIP ESSENCE BALM | 7.2 g in 1 CARTON | CREAM | 7.2 | 1 |
DailyMed Dashboard NDC Coverage#
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| OCTINOXATE | ACTIVE INGREDIENT | 4Y5P7MUD51 | 1 | |
| OCTINOXATE | ACTIVE MOIETY | 4Y5P7MUD51 | 1 | |
| Petrolatum | INACTIVE INGREDIENT | 4T6H12BN9U | 1 | |
| Silica Dimethyl Silylate | INACTIVE INGREDIENT | EU2PSP0G0W | 1 |
Products#
Every source-derived product name is available through these pages.
- TONYMOLY KISS KISS LIP ESSENCE BALM
- OCTINOXATE
- Petrolatum
- Silica Dimethyl Silylate
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 59078-046 | 59078-046-01 |
Ingredients#
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| OCTINOXATE | 4Y5P7MUD51 | ACTIB |
| Petrolatum | 4T6H12BN9U | IACT |
| Silica Dimethyl Silylate | EU2PSP0G0W | IACT |
Source Document#
Inactive ingredient matches#
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| Petrolatum | PETROLATUM | 4T6H12BN9U | SOAP / TOPICAL | 0.85 %w/w | ||
| Silica Dimethyl Silylate | SILICA DIMETHYL SILYLATE | EU2PSP0G0W | CREAM / VAGINAL | 50 mg | ||
| Petrolatum | PETROLATUM | 4T6H12BN9U | CAPSULE, EXTENDED RELEASE / ORAL | 0.07 mg | ||
| Silica Dimethyl Silylate | SILICA DIMETHYL SILYLATE | EU2PSP0G0W | TABLET / SUBLINGUAL | 2 mg | ||
| Petrolatum | PETROLATUM | 4T6H12BN9U | EMULSION / TOPICAL | 7.8 %w/w | ||
| Silica Dimethyl Silylate | SILICA DIMETHYL SILYLATE | EU2PSP0G0W | TABLET, FILM COATED / ORAL | 2 mg | ||
| Silica Dimethyl Silylate | SILICA DIMETHYL SILYLATE | EU2PSP0G0W | TABLET, EXTENDED RELEASE / ORAL | 10 mg | ||
| Petrolatum | PETROLATUM | 4T6H12BN9U | AEROSOL, FOAM / TOPICAL | 7.9 %w/w | ||
| Petrolatum | PETROLATUM | 4T6H12BN9U | OINTMENT, AUGMENTED / TOPICAL | 81.94 %w/w | ||
| Silica Dimethyl Silylate | SILICA DIMETHYL SILYLATE | EU2PSP0G0W | CAPSULE / ORAL | 0.5 mg | ||
| Petrolatum | PETROLATUM | 4T6H12BN9U | CREAM / TOPICAL | 4213 mg | ||
| Petrolatum | PETROLATUM | 4T6H12BN9U | TABLET / ORAL | 3.5 mg | ||
| Silica Dimethyl Silylate | SILICA DIMETHYL SILYLATE | EU2PSP0G0W | SUSPENSION / ORAL | 120 mg | ||
| Petrolatum | PETROLATUM | 4T6H12BN9U | OINTMENT / AURICULAR (OTIC) | NA | ||
| Petrolatum | PETROLATUM | 4T6H12BN9U | LIQUID / RESPIRATORY (INHALATION) | NA | ||
| Petrolatum | PETROLATUM | 4T6H12BN9U | OINTMENT / TOPICAL | 7275 mg | ||
| Petrolatum | PETROLATUM | 4T6H12BN9U | OINTMENT / OPHTHALMIC | 88.4 %w/w | ||
| Petrolatum | PETROLATUM | 4T6H12BN9U | CREAM, AUGMENTED / TOPICAL | 26 %w/w | ||
| Silica Dimethyl Silylate | SILICA DIMETHYL SILYLATE | EU2PSP0G0W | TABLET / ORAL | 8 mg | ||
| Petrolatum | PETROLATUM | 4T6H12BN9U | SUPPOSITORY / VAGINAL | 27 mg | ||
| Petrolatum | PETROLATUM | 4T6H12BN9U | TABLET, EXTENDED RELEASE / ORAL | 0.18 mg | ||
| Petrolatum | PETROLATUM | 4T6H12BN9U | LOTION / TOPICAL | 25 %w/w | ||
| Petrolatum | PETROLATUM | 4T6H12BN9U | SPONGE / TOPICAL | NA | ||
| Petrolatum | PETROLATUM | 4T6H12BN9U | OINTMENT / VAGINAL | 4084 mg | ||
| Petrolatum | PETROLATUM | 4T6H12BN9U | CAPSULE / VAGINAL | NA |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 53cc4347-b0da-4dfb-b9ed-e13dd2846ff5 | 71b73c2e-bdb8-4202-b491-42f2b7881e05 | 2014-06-25 | Warnings | 53cc4347-b0da-4dfb-b9ed-e13dd2846ff5 71b73c2e-bdb8-4202-b491-42f2b7881e05 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.